Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
10.15%
Price
05.03.26
€316.75
Summary
This prediction is currently active. The BUY prediction by Scotiabank currently has a performance of 10.15%. Dividends of €4.90 are taken into consideration when calculating the performance. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.061% | 0.061% |
| iShares Core DAX® | -3,81 % | -1,47 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % |
| iShares S&P 500 | 0,25 % | 1,23 % |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat